Search for other papers by Piera Rizzolo in
Google Scholar
PubMed
Search for other papers by Valentina Silvestri in
Google Scholar
PubMed
Search for other papers by Virginia Valentini in
Google Scholar
PubMed
Search for other papers by Veronica Zelli in
Google Scholar
PubMed
Search for other papers by Agostino Bucalo in
Google Scholar
PubMed
Search for other papers by Ines Zanna in
Google Scholar
PubMed
Search for other papers by Simonetta Bianchi in
Google Scholar
PubMed
Search for other papers by Maria Grazia Tibiletti in
Google Scholar
PubMed
Search for other papers by Antonio Russo in
Google Scholar
PubMed
Search for other papers by Liliana Varesco in
Google Scholar
PubMed
Search for other papers by Gianluca Tedaldi in
Google Scholar
PubMed
Search for other papers by Bernardo Bonanni in
Google Scholar
PubMed
Search for other papers by Jacopo Azzollini in
Google Scholar
PubMed
Search for other papers by Siranoush Manoukian in
Google Scholar
PubMed
Search for other papers by Anna Coppa in
Google Scholar
PubMed
Search for other papers by Giuseppe Giannini in
Google Scholar
PubMed
Search for other papers by Laura Cortesi in
Google Scholar
PubMed
Search for other papers by Alessandra Viel in
Google Scholar
PubMed
Search for other papers by Marco Montagna in
Google Scholar
PubMed
Search for other papers by Paolo Peterlongo in
Google Scholar
PubMed
Search for other papers by Paolo Radice in
Google Scholar
PubMed
Search for other papers by Domenico Palli in
Google Scholar
PubMed
Search for other papers by Laura Ottini in
Google Scholar
PubMed
in genes involved in estrogen biosynthesis and metabolism pathways, such as Cytochrome P450 family 17 subfamily A member 1 ( CYP17A1 ) and Cytochrome P450 family 1 subfamily B member 1 ( CYP1B1 ), may cause an increased risk of hormone-related cancers
Search for other papers by Qiuli Liu in
Google Scholar
PubMed
Search for other papers by Lin-ang Wang in
Google Scholar
PubMed
Search for other papers by Jian Su in
Google Scholar
PubMed
Search for other papers by Dali Tong in
Google Scholar
PubMed
Search for other papers by Weihua Lan in
Google Scholar
PubMed
Search for other papers by Luofu Wang in
Google Scholar
PubMed
Search for other papers by Gaolei Liu in
Google Scholar
PubMed
Search for other papers by Jun Zhang in
Google Scholar
PubMed
AmCare Genomics Lab, Guangzhou, People’s Republic of China
Search for other papers by Victor Wei Zhang in
Google Scholar
PubMed
Search for other papers by Dianzheng Zhang in
Google Scholar
PubMed
Search for other papers by Rongrong Chen in
Google Scholar
PubMed
Search for other papers by Qingyi Zhu in
Google Scholar
PubMed
Search for other papers by Jun Jiang in
Google Scholar
PubMed
. Six cytochrome P450 (CYP) enzymes including CYP11A1, CYP11B1, CYP11B2, CYP17A1, CYP19A1 and CYP21A2 are involved in the synthesis of steroid hormones. Although deficiencies of any of these enzymes can result in CAH ( 3 ), CYP21A2 deficiency (21OHD
Inserm U1016-CNRS UMR8104, Paris, France
Hormonology Department, Cochin Hospital, Paris, France
Search for other papers by Fidéline Bonnet-Serrano in
Google Scholar
PubMed
Inserm U1016-CNRS UMR8104, Paris, France
Radiology Department, Cochin Hospital, Paris, France
Search for other papers by Maxime Barat in
Google Scholar
PubMed
Inserm U1016-CNRS UMR8104, Paris, France
Reference Center for Rare Adrenal Diseases, Endocrinology Department, Cochin Hospital, Paris, France
Search for other papers by Anna Vaczlavik in
Google Scholar
PubMed
Search for other papers by Anne Jouinot in
Google Scholar
PubMed
Inserm U1016-CNRS UMR8104, Paris, France
Reference Center for Rare Adrenal Diseases, Endocrinology Department, Cochin Hospital, Paris, France
Search for other papers by Lucas Bouys in
Google Scholar
PubMed
Hormonology Department, Cochin Hospital, Paris, France
INSERM, Physiopathologie et Pharmacotoxicologie Placentaire Humaine : Microbiote Pré & Post natal, Paris, France
Search for other papers by Christelle Laguillier-Morizot in
Google Scholar
PubMed
Search for other papers by Corinne Zientek in
Google Scholar
PubMed
Search for other papers by Catherine Simonneau in
Google Scholar
PubMed
Inserm U1016-CNRS UMR8104, Paris, France
Diabetology Department, Cochin Hospital, Paris, France
Search for other papers by Etienne Larger in
Google Scholar
PubMed
Search for other papers by Laurence Guignat in
Google Scholar
PubMed
Inserm U1016-CNRS UMR8104, Paris, France
Reference Center for Rare Adrenal Diseases, Endocrinology Department, Cochin Hospital, Paris, France
Search for other papers by Lionel Groussin in
Google Scholar
PubMed
Inserm U1016-CNRS UMR8104, Paris, France
Reference Center for Rare Adrenal Diseases, Endocrinology Department, Cochin Hospital, Paris, France
Search for other papers by Guillaume Assié in
Google Scholar
PubMed
Hormonology Department, Cochin Hospital, Paris, France
INSERM, Physiopathologie et Pharmacotoxicologie Placentaire Humaine : Microbiote Pré & Post natal, Paris, France
Search for other papers by Jean Guibourdenche in
Google Scholar
PubMed
UR 7537 BioSTM, Paris, France
Search for other papers by Ioannis Nicolis in
Google Scholar
PubMed
Search for other papers by Marie-Claude Menet in
Google Scholar
PubMed
Inserm U1016-CNRS UMR8104, Paris, France
Reference Center for Rare Adrenal Diseases, Endocrinology Department, Cochin Hospital, Paris, France
Search for other papers by Jérôme Bertherat in
Google Scholar
PubMed
precursor, located upstream of the deficient enzyme. In this context, CYP21A2 enzyme is the most frequently affected in patients with congenital adrenal hyperplasia (CAH), leading to an excessive response of 17-hydroxyprogesterone (17OHP) to ACTH1-24. In
Search for other papers by Ingeborg Brønstad in
Google Scholar
PubMed
Search for other papers by Lars Breivik in
Google Scholar
PubMed
Department of Clinical Science, Department of Medicine, Division of Medicine, University of Bergen, 5021 Bergen, Norway
Search for other papers by Paal Methlie in
Google Scholar
PubMed
Search for other papers by Anette S B Wolff in
Google Scholar
PubMed
Search for other papers by Eirik Bratland in
Google Scholar
PubMed
Search for other papers by Ingrid Nermoen in
Google Scholar
PubMed
Department of Clinical Science, Department of Medicine, Division of Medicine, University of Bergen, 5021 Bergen, Norway
Search for other papers by Kristian Løvås in
Google Scholar
PubMed
Department of Clinical Science, Department of Medicine, Division of Medicine, University of Bergen, 5021 Bergen, Norway
Search for other papers by Eystein S Husebye in
Google Scholar
PubMed
by signs of hyperandrogenism postnatally and in adulthood, and associated with minor mutations (3) . The most common mutations in the CYP21A2 gene are derived from a non-functional pseudogene CYP21A1P (4) . Both CYP21A2 and CYP21A1P are
Search for other papers by I Savchuk in
Google Scholar
PubMed
Search for other papers by M L Morvan in
Google Scholar
PubMed
Search for other papers by J P Antignac in
Google Scholar
PubMed
Search for other papers by K Gemzell-Danielsson in
Google Scholar
PubMed
Search for other papers by B Le Bizec in
Google Scholar
PubMed
Search for other papers by O Söder in
Google Scholar
PubMed
Search for other papers by K Svechnikov in
Google Scholar
PubMed
, androsterone, androstanediol and DHT by the action of 5α-reductase 1 (SRD5A1), CYP17A1, the family of 3α-HSD1–4 (AKR1C1–4), 17βHSD3 and 17βHSD6 (HSD17B3, HSD17B6) ( 9 , 11 ). Recent studies have reported the presence of a backdoor pathway of DHT synthesis in
Search for other papers by Arpna Sharma in
Google Scholar
PubMed
Search for other papers by Vijay Simha Baddela in
Google Scholar
PubMed
Search for other papers by Frank Becker in
Google Scholar
PubMed
Search for other papers by Dirk Dannenberger in
Google Scholar
PubMed
Search for other papers by Torsten Viergutz in
Google Scholar
PubMed
Search for other papers by Jens Vanselow in
Google Scholar
PubMed
(Bioline, Luckenwalde, Germany) from 200 ng RNA as previously described ( 17 ). Quantitative real-time PCR (qPCR) analysis qPCR was performed using SensiFAST SYBR No-ROX (Bioline, London, UK) with gene-specific primers ( Table 1 ) in a Light Cycler
Search for other papers by Britt J van Keulen in
Google Scholar
PubMed
Search for other papers by Conor V Dolan in
Google Scholar
PubMed
Search for other papers by Bibian van der Voorn in
Google Scholar
PubMed
Search for other papers by Ruth Andrew in
Google Scholar
PubMed
Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
Search for other papers by Brian R Walker in
Google Scholar
PubMed
Search for other papers by Hilleke Hulshoff Pol in
Google Scholar
PubMed
Search for other papers by Dorret I Boomsma in
Google Scholar
PubMed
Search for other papers by Joost Rotteveel in
Google Scholar
PubMed
Search for other papers by Martijn J J Finken in
Google Scholar
PubMed
activity is higher in women than in men. However, CYP3A4 is known to eliminate only a small proportion of circulating cortisol ( 16 , 17 ). There is controversy as to whether men and women differ in the activities of 11β-HSDs ( 14 , 18 , 19 , 20
Search for other papers by Xingyan Liu in
Google Scholar
PubMed
Search for other papers by Mei Xu in
Google Scholar
PubMed
Search for other papers by Min Qian in
Google Scholar
PubMed
Search for other papers by Lindong Yang in
Google Scholar
PubMed
augmented with which compared normal women by isolation and cultivation of theca cells ( 8 , 9 ). The excess biosynthesis of androgen in PCOS was attributed to the enhanced expression of steroid-17-α-hydroxylase/17,20 lyase (CYP17A1 gene) in theca cells
Search for other papers by Sarmistha Banerjee in
Google Scholar
PubMed
Search for other papers by Allison M Hayes in
Google Scholar
PubMed
Search for other papers by Bernard H Shapiro in
Google Scholar
PubMed
in CYP expression and resulting drug metabolism observed during adulthood ( 1 , 5 ). Most, if not all, sexual dimorphisms are a result of developmental hormone imprinting. Hormonal imprinting refers to a biological process in which the target
Regenerative Medicine Institute at CÚRAM SFI Research Centre, School of Medicine, National University of Ireland Galway (NUIG), Galway, Ireland
Search for other papers by Tomás P Griffin in
Google Scholar
PubMed
Search for other papers by Caroline M Joyce in
Google Scholar
PubMed
Search for other papers by Sumaya Alkanderi in
Google Scholar
PubMed
Search for other papers by Liam M Blake in
Google Scholar
PubMed
Search for other papers by Derek T O’Keeffe in
Google Scholar
PubMed
Search for other papers by Delia Bogdanet in
Google Scholar
PubMed
Department of Clinical Biochemistry, SUHCG, GUH, Galway, Ireland
Search for other papers by Md Nahidul Islam in
Google Scholar
PubMed
Lambe Institute for Translational Research, School of Medicine, NUIG, Galway, Ireland
Search for other papers by Michael C Dennedy in
Google Scholar
PubMed
Search for other papers by John E Gillan in
Google Scholar
PubMed
Search for other papers by John J Morrison in
Google Scholar
PubMed
Regenerative Medicine Institute at CÚRAM SFI Research Centre, School of Medicine, National University of Ireland Galway (NUIG), Galway, Ireland
Search for other papers by Timothy O’Brien in
Google Scholar
PubMed
Newcastle upon Tyne NHS Hospitals Foundation Trust, Newcastle upon Tyne, UK
NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne, UK
Search for other papers by John A Sayer in
Google Scholar
PubMed
Search for other papers by Marcia Bell in
Google Scholar
PubMed
Search for other papers by Paula M O’Shea in
Google Scholar
PubMed
series of reactions in the liver and kidneys to generate the active form ( 5 ). In the liver, vitamin D3 is hydroxylated to form the prehormone 25-hydroxycholecalciferol D (25(OH)D 3 ) catalysed primarily by CYP2R1 with CYP27A1 possibly contributing